B. Joseph Guglielmo Jr.


B. Joseph Guglielmo, Jr. is a pharmacist at 360: The Positive Care Center at UCSF Medical Center, where he collaborates with members of the medical team to optimize patient drug therapies, conducts medication history interviews and meets with patients to answer questions about drug regimens.

Guglielmo earned a doctor of pharmacy degree at the University of Southern California's School of Pharmacy and completed a residency in pharmacy at UCSF's School of Pharmacy. He is a member of several professional societies, including the Infectious Diseases Society of America, American Society of Health Systems Pharmacists and American College of Clinical Pharmacists. He is vice chair of the department of clinical pharmacy at UCSF.

Academic Title

Professor of Clinical Pharmacy

Selected Research and Publications

  1. Meyer-Massetti C, Meier CR, Guglielmo BJ. The scope of drug-related problems in the home care setting. Int J Clin Pharm. 2018 Jan 11.
  2. Roy SL, Atkins JT, Gennuso R, Kofos D, Sriram RR, Dorlo TP, Hayes T, Qvarnstrom Y, Kucerova Z, Guglielmo BJ, Visvesvara GS. Assessment of blood-brain barrier penetration of miltefosine used to treat a fatal case of granulomatous amebic encephalitis possibly caused by an unusual Balamuthia mandrillaris strain. Parasitol Res. 2015 Dec; 114(12):4431-9.
  3. Cheng CM, Shin J, Guglielmo BJ. Trends in boxed warnings and withdrawals for novel therapeutic drugs, 1996 through 2012. JAMA Intern Med. 2014 Oct; 174(10):1704-5.
  4. Hardmeier A, Tsourounis C, Moore M, Abbott WE, Guglielmo BJ. Pediatric medication administration errors and workflow following implementation of a bar code medication administration system. J Healthc Qual. 2014 Jul-Aug; 36(4):54-61; quiz 61-3.
  5. Gahbauer AM, Gonzales ML, Guglielmo BJ. Patterns of antibacterial use and impact of age, race/ethnicity, and geographic region on antibacterial use in an outpatient medicaid cohort. Pharmacotherapy. 2014 Jul; 34(7):677-85.
  6. Tan M, Lau J, Guglielmo BJ. Ethanol locks in the prevention and treatment of catheter-related bloodstream infections. Ann Pharmacother. 2014 May; 48(5):607-15.
  7. Frymoyer A, Guglielmo BJ, Hersh AL. Desired vancomycin trough serum concentration for treating invasive methicillin-resistant Staphylococcal infections. Pediatr Infect Dis J. 2013 Oct; 32(10):1077-9.
  8. Frymoyer A, Lee S, Bonifacio SL, Meng L, Lucas SS, Guglielmo BJ, Sun Y, Verotta D. Every 36-h gentamicin dosing in neonates with hypoxic-ischemic encephalopathy receiving hypothermia. J Perinatol. 2013 Oct; 33(10):778-82.
  9. Gwaza L, Aweeka F, Greenblatt R, Lizak P, Huang L, Guglielmo BJ. Co-administration of a commonly used Zimbabwean herbal treatment (African potato) does not alter the pharmacokinetics of lopinavir/ritonavir. Int J Infect Dis. 2013 Oct; 17(10):e857-61.
  10. Frymoyer A, Meng L, Bonifacio SL, Verotta D, Guglielmo BJ. Gentamicin pharmacokinetics and dosing in neonates with hypoxic ischemic encephalopathy receiving hypothermia. Pharmacotherapy. 2013 Jul; 33(7):718-26.
  11. Burrell C, Tsourounis C, Quan D. Impact of a pharmacist-driven protocol to improve drug allergy documentation at a university hospital. Hosp Pharm. 2013 Apr; 48(4):302-7.
  12. Cocohoba JM, Murphy P, Pietrandoni G, Guglielmo BJ. Improved antiretroviral refill adherence in HIV-focused community pharmacies. J Am Pharm Assoc (2003). 2012 Sep-Oct; 52(5):e67-73.
  13. Murphy P, Cocohoba J, Tang A, Pietrandoni G, Hou J, Guglielmo BJ. Impact of HIV-specialized pharmacies on adherence and persistence with antiretroviral therapy. AIDS Patient Care STDS. 2012 Sep; 26(9):526-31.
  14. Swartling M, Gupta R, Dudas V, Guglielmo BJ. Short term impact of guidelines on vancomycin dosing and therapeutic drug monitoring. Int J Clin Pharm. 2012 Apr; 34(2):282-5.
  15. Cheng CM, Fu C, Guglielmo BJ, Auerbach AD. Boxed warning inconsistencies between drug information resources and the prescribing information. Am J Health Syst Pharm. 2011 Sep 01; 68(17):1626-31.
  16. Frymoyer A, Guglielmo BJ, Wilson SD, Scarpace SB, Benet LZ, Hersh AL. Impact of a hospitalwide increase in empiric pediatric vancomycin dosing on initial trough concentrations. Pharmacotherapy. 2011 Sep; 31(9):871-6.
  17. Guglielmo BJ, Edwards DJ, Franks AS, Naughton CA, Schonder KS, Stamm PL, Thornton P, Popovich NG. A critical appraisal of and recommendations for faculty development. Am J Pharm Educ. 2011 Aug 10; 75(6):122.
  18. Meyer-Massetti C, Vaerini S, Rätz Bravo AE, Meier CR, Guglielmo BJ. Comparative safety of antipsychotics in the WHO pharmacovigilance database: the haloperidol case. Int J Clin Pharm. 2011 Oct; 33(5):806-14.
  19. Cheng C, Guglielmo BJ. Invited commentary--prescription drug label adverse events: a call for prioritization: comment on "A quantitative analysis of adverse events and 'overwarning' in drug labeling". Arch Intern Med. 2011 May 23; 171(10):946-7.
  20. Meyer-Massetti C, Cheng CM, Schwappach DL, Paulsen L, Ide B, Meier CR, Guglielmo BJ. Systematic review of medication safety assessment methods. Am J Health Syst Pharm. 2011 Feb 01; 68(3):227-40.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.

This health care professional is not a member of UCSF Medical Group. Please check with your health insurance plan regarding coverage for services.